Previous Close | 1.1800 |
Open | 1.2100 |
Bid | 1.2000 x N/A |
Ask | 1.2500 x N/A |
Day's Range | 1.2100 - 1.2100 |
52 Week Range | 0.7200 - 2.9800 |
Volume | |
Avg. Volume | 21,429 |
Market Cap | 60.621M |
Beta (5Y Monthly) | 1.68 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1000 |
Earnings Date | Apr 27, 2024 - May 01, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
MustGrow has received The State of Oregon Agriculture approval to commence sales of TerraSanteTM, an organic biofertility product, in Oregon State.MustGrow's recently-awarded organic compliance certification from the USDA National Organic Program (OMRI Listed®) will apply to this Registration.Mustard-derived TerraSanteTM focuses on soil microbiome health, nutrient/water use efficiencies, and plant yields.Saskatoon, Saskatchewan--(Newsfile Corp. - February 6, 2024) - MustGrow Biologics Corp. (TSX
Saskatoon, Saskatchewan--(Newsfile Corp. - December 13, 2023) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) ("MustGrow") wishes to provide additional information about the collaboration agreement (the "Agreement") with Bayer AG ("Bayer") which was announced December 11, 2023. The Agreement is a license and collaboration agreement enabling Bayer to further evaluate certain soil applications of MustGrow's mustard-based biocontrol technologies and to develop, formulate and comme
MustGrow Biologics CEO Corey Giasson joined Steve Darling from Proactive to share news the company has signed a collaboration agreement with Bayer AG that focuses on the soil applications of MustGr...